• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number JHJR071002J
Device Problem Partial Blockage (1065)
Patient Problems Stenosis (2263); Pseudoaneurysm (2605)
Event Date 06/01/2019
Event Type  Injury  
Manufacturer Narrative
Review of the manufacturing records could not be performed as no lot number information was provided.The device was not returned.Consequently, direct product analysis was not possible.Additional information about this event could not be obtained.As a result, no conclusion can be drawn.All information has been placed on file for use in tracking and trending.
 
Event Description
The following publication was reviewed: two cases of viabahn implantation for the subclavian arterial injury.This patient is a man in his forties.On an unknown date, the patient fall during snowboarding.Three days later, swelling and pain in the right shoulder got worse, and the patient was referred to the hospital.Computed tomography angiography (cta) was performed, and pseudoaneurysm and arteriovenous fistula in the distal portion of the right subclavian artery was suspected.The patient was in poor general condition due to bleeding, and it was elected to utilize gore® viabahn® endoprosthesis with heparin bioactive surface.A micro guidewire was inserted from the right upper arm and a snare system was inserted from the right common iliac artery to apply pull-through technique.The endoprosthesis was implanted in the right subclavian artery with no reported issue.Three days after the procedure, cta confirmed that the pseudoaneurysm and the arteriovenous fistula disappeared.The patient discharged from the hospital seven days after the procedure.Four months after the procedure, ct showed a middle stenosis around proximal portion of the endoprosthesis and mild stenosis located distal to the first stenosis region.However, contrast effect remained in its distal area.No further issue was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
nick la fave
9285263030
MDR Report Key9226515
MDR Text Key163954927
Report Number2017233-2019-01082
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P130006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial
Report Date 10/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/23/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberJHJR071002J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age40 YR
-
-